Association Between Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510(k) Clearance
Open Access
- 10 January 2023
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 329 (2) , 144-156
Abstract
In the US, most moderate-risk medical devices enter the market through the US Food and Drug Administration (FDA) 510(k) clearance pathway because they are “substantially equivalent” to 1 or more “predicate” devices (legally marketed devices with similar intended use).1,2 The FDA often evaluates substantial equivalence via similarities in the composition and design between applicant medical devices and predicate medical devices, and human clinical data for the applicant device or the predicate device are not typically required.3 Manufacturers may cite competitors’ devices or recalled devices as predicate medical devices as long as the recalled devices were voluntarily recalled by their manufacturers.4,5Keywords
This publication has 11 references indexed in Scilit:
- Mapping the genealogy of medical device predicates in the United StatesPLOS ONE, 2021
- FDA Regulation and Approval of Medical Devices: 1976-2020JAMA, 2021
- The 510(k) Ancestry of Transvaginal MeshJAMA Surgery, 2021
- Risk of Recall Among Medical Devices Undergoing US Food and Drug Administration 510(k) Clearance and Premarket Approval, 2008-2017JAMA Network Open, 2021
- The regulatory ancestral network of surgical meshesPLOS ONE, 2018
- Lack of Publicly Available Scientific Evidence on the Safety and Effectiveness of Implanted Medical DevicesJAMA Internal Medicine, 2014
- The 510(k) Ancestry of a Metal-on-Metal Hip ImplantNew England Journal of Medicine, 2013
- Public Health Effectiveness of the FDA 510(k) Clearance Process2011
- Bias in Conditional and Unconditional Fixed Effects Logit Estimation: A CorrectionPolitical Analysis, 2005
- Bias in Conditional and Unconditional Fixed Effects Logit EstimationPolitical Analysis, 2001